Appearance of anti-DNA antibodies in patients treated with interferon-alpha.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Arthritis & Rheumatism

• Publication date

  1993-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780360224PMID 8431220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-DNA antibodies in the primary antiphospholipid syndrome.

  1993cited by this paper
• Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

  1991cited by this paper
• Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour

  1990cited by this paper
• The mosaic of autoimmunity.

  1989cited by this paper
• Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.

  1981cited by this paper

• Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE)

  2025cites this paper
• Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus

  2024cites this paper
• Skin lesions in systemic lupus erythematosus. Part 1: classification, etiology, pathogenesis

  2022cites this paper
• An Update on the Pathogenesis of Skin Damage in Lupus

  2020cites this paper
• Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients.

  2020cites this paper
• Conditional Upregulation of IFN-α Alone Is Sufficient to Induce Systemic Lupus Erythematosus

  2019cites this paper
• A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.

  2018cites this paper
• Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus

  2017cites this paper
• Mediators of Inflammation and Their Effect on Resident Renal Cells: Implications in Lupus Nephritis

  2013cites this paper
• Chapter 51 – Specialized Treatment Approaches and Niche Therapies for Lupus Subsets

  2013cites this paper
• Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.

  2012cites this paper
• Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes

  2011cites this paper
• Drug-Induced Disease

  2011cites this paper
• Functions of Toll-like receptors as an inborn immunity component and their participation in the pathogenesis of dermatoses of different etiologies

  2011cites this paper
• Inhibition of a C‐rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice

  2010cites this paper
• Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production.

  2010cites this paper
• Potent Induction of IFN-α and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus1

  2009cites this paper
• Toll‐like receptors and dermatology

  2009cites this paper
• Patients with Neuropsychiatric Lupus by Autoantibodies in the Cerebrospinal Fluid and Chemokines α Potent Induction of IFN-Möller and

  2008cites this paper
• Dysfunctional interferon-α production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus

  2008cites this paper
• Endogenous Type I Interferon Inducers in Systemic Autoimmune Diseases

  2006cites this paper
• Interferon-induced sarcoidosis.

  2006cites this paper
• Rôle des cellules dendritiques et de l'interféron alpha dans le lupus érythémateux systémique

  2005cites this paper
• Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes.

  2005cites this paper
• Reduced blood BDCA‐2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus

  2005cites this paper
• Immunothérapies du lupus systémique : innovations et perspectives

  2005cites this paper
• Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

  2004cites this paper
• The role of cytokines in the immunopathogenesis of lupus

  2004cites this paper
• Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.

  2004cites this paper
• 45 – DRUG AND ENVIRONMENTAL LUPUS: CLINICAL MANIFESTATIONS AND DIFFERENCES

  2004cites this paper
• Autoantibodies and the Type I Interferon System in the Etiopathogenesis of Systemic Lupus Erythematosus

  2003cites this paper
• Autoantibodies and the Type I Interferon System in the Etiopathogenesis of Systemic Lupus Erythematosus

  2003cites this paper
• The central role of dendritic cells and interferon-alpha in SLE.

  2003cites this paper
• Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α

  2003cites this paper
• Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.

  2003cites this paper
• Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.

  2003cites this paper
• Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.

  2003cites this paper
• FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgG 1

  2003cites this paper
• The central role of dendritic cells and interferon-&agr; in SLE

  2003cites this paper
• Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

  2001cites this paper
• BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction

  2001cites this paper
• Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus

  2001cites this paper
• Pleural effusion during interferon treatment for chronic hepatitis C.

  2000cites this paper
• Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

  2000cites this paper
• The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.

  2000cites this paper
• Inducer a and Lupus IgG Is a Potent IFN-The Combination of Apoptotic U937 Cells

  2000cites this paper
• Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

  2000cites this paper
• Musculoskeletal and systemic reactions to biological therapeutic agents.

  2000cites this paper
• Chapter 41 – Postchemotherapy Rheumatism

  2000cites this paper
• The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer3

  2000cites this paper
• Interferon-a-assoziierte Polyarthritis Mögliche Induktion einer seropositiven rheumatoiden Arthritis durch Interferon-a: zwei Fallbeispiele und Literaturübersicht

  1999cites this paper
• Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.

  1999cites this paper
• [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].

  1999cites this paper
• Immunological treatment of autoimmune diseases.

  1998cites this paper
• Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon.

  1998cites this paper
• Increased anxiety behaviors in autoimmune mice.

  1996cites this paper
• [Side effects of interferon-alpha].

  1996cites this paper
• Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases.

  1995cites this paper
• Immune-mediated side-effects of cytokines in humans.

  1995cites this paper
• Role of the Biologics in Autoimmunity

  1994cites this paper
• Drugs Recently Associated With Lupus Syndromes

  1994cites this paper
• Lymphokines in autoimmunity--a critical review.

  1994cites this paper
• Blood, blood components, plasma, and plasma products

  1993cites this paper
• Systemic lupus erythematosus

  1956cites this paper